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Hyperoxia causes pulmonary toxicity in part by injuring alveolar
epithelial cells. Previous studies have shown that toxic oxygen-
derived species damage DNA and this damage is recognized and







 enzyme formamidopyrimidine DNA
 





-mediated DNA damage in lung cells, A549 lung epi-
thelial cells were transduced with either hOgg1 or Fpg using a ret-
roviral vector containing enhanced green fluorescent protein. Ex-
pression of each gene in the transduced cells was confirmed by
fluorescent microscopy, Northern blotting, Western blotting, and
 
an enzymatic oligonucleotide cleavage assay. A549 cells expressing
either hOgg1 or Fpg were protected from hyperoxia as evidenced
by a decrease in DNA damage and a corresponding increase in cell
survival. Further, we determined that overexpression of hOgg1 or
Fpg partially mitigated the toxic effects of hydrogen peroxide in
lung cells. Our data suggest that increased expression of DNA
base excision repair genes might represent a new approach for
protecting critical lung cells from the toxic effects of hyperoxia.
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High concentrations of oxygen are often required to maintain
normoxemia in acute lung injury; yet, hyperoxia is also a com-
mon cause of acute lung injury (1). Current evidence indicates
that the damaging effects of oxygen are mediated by reactive
 







Oxygen and ROS can damage alveolar epithelial cells, leading
to loss of the alveolar capillary barrier function (5). Mecha-
nisms of oxygen-mediated lung injury include lipid peroxida-
tion of cell membrane, structural damage of key proteins, and
depletion of cellular reducing agents such as the reduced form
of nicotinamide adenine dinucleotide phosphate (6).
Hyperoxia has been thought to be a cause of DNA damage
and mutagenesis for decades (7, 8). More recent studies indi-
cate that oxidant-mediated lung injury is associated with DNA
damage as evidenced by an increase in p53 and p53-related
gene products (9–11). Nonetheless, it is not clear how DNA
damage and acute lung injury are linked and whether repair of
acute DNA damage will reduce lung cell injury.
Oxygen and other oxidizing agents cause DNA single- and
double-strand breaks that may result in cell death (12, 13).





-deoxyguanosine and imidazole ring–opened gua-
nine (Fapy-Gua), followed by imidazole ring–opened adenine
(Fapy-Ade) and cytosine glycol (14). Generation of oxidative
DNA damage is prevented by antioxidant enzymes such as
catalase (14) and superoxide dismutase (14) by reducing the
amount and toxicity of ROS.
Eukaryotes possess a number of DNA repair enzymes that
can rapidly reverse DNA damage. One of the key DNA repair
enzymes involved in the base excision repair (BER) pathway
in human cells to reverse oxidant-mediated DNA damage is
8-oxoguanine DNA glycosylase (hOgg1) (15, 16). hOgg1 is a





mamidopyrimidine-DNA glycosylase (Fpg) (17, 18). hOgg1 re-
moves 7,8-dihydro-8-oxoguanine (8-oxoG) and other oxidative
guanine modifications from nuclear and mitochondrial DNA.
hOgg1 is present in mitochondria as well as in nuclei of human
cells (19), as mitochondrial DNA is even more prone to oxi-
dant-mediated damage than nuclear DNA is (20, 21). Wilson
and colleagues have reported that BER protein Ogg1 can re-
pair mtDNA damage in human cells (22). Deletion of the Ogg1
gene results in accumulation of 8-oxoG and an increase in mu-
tational risk (23, 24). Fpg repairs 8-oxo purines, FaPy purines,
and the imidazole ring–opened aminoethyl purines (25). Ogg1
deficiency in yeast, as well as Fpg deficiency in bacteria, results
in a spontaneous mutator phenotype (26).
Although hOgg1 and Fpg are considered prime candidates
for repair of oxidant-mediated DNA damage (27–31), it is not
known whether these DNA repair proteins can protect mam-




 Thus, we hypothesized that
overexpression of hOgg1 or Fpg in lung cells might enhance
resistance to hyperoxic injury. hOgg1 or Fpg was transduced
into A549 alveolar epithelial cells using a retroviral vector
pSF91. The cells transduced with either hOgg1 or Fpg were
more resistant to hyperoxia when compared with vector con-
trol cells with less DNA damage, and enhanced cell survival.
Further, overexpression of either hOgg1 or Fpg protected hu-








-induced DNA damage. These data
suggest that rapid reversal of oxidant-mediated DNA damage













was a gift of Dr. C. Baum, University of Hamburg, Germany
(32). The bicistronic retroviral vector pSF91 was essentially con-
structed as described previously (33), with an internal ribosome entry
site (IRES) upstream to the gene expressing enhanced green fluores-
cence protein (EGFP).
hOgg1 was a gift from Dr. S. Mitra (University of Texas Medical
School, Galveston, TX). The hOgg1–6 cDNA was amplified by poly-



















) to introduce a Kozak
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 end of the gene to increase translation efficiency








I and then ligated,




competent cells (Life Technologies, Gaithersburg, MD), colonies con-









-hOgg1–6 primer. The inserts were sequenced to confirm
the integrity of the hOgg1–6 gene. The hOgg1–6 sequence is identical
to that previously reported (15, 16), except that it lacks the 6 C-termi-
nal codons (amino acids 317–322) of the wild-type gene. Eight micro-
grams of purified vector DNA was mixed with LipofectAMINE (Life
Technologies) and transfected into phoenix-AMPHO cells. The viral









E86 cells exhibiting high fluorescent intensity were selected as

















m Acrodisc filter (Gelman Sci-
ences, Ann Arbor, MI), and the filtered supernatant was incubated





(Sigma, St. Louis, MO). After 36 hours, the infected cells were selected by
fluorescence-activated cell sorting.




 cells using PCR

















of the gene, respectively (31, 33). The reaction conditions used for




 polymerase (Promega, Madison,
WI) protocol. The PCR product and vector pGEX 4T-1 (Amersham








I, and the purified DNAs were ligated using T4 ligase (Life Tech-
nologies). After confirming the DNA sequence of the insert, the Fpg
cDNA within the pGEX4T-1 vector was amplified in another round




 end of the gene








I and ligated to linearized pSF91 vector using T4 ligase.
The transient and stable producer cells were constructed and used to












) using the RNeasy
Mini Kit (Qiagen, Valencia, CA) as per the manufacturer’s instruc-
 




g) was separated in a 1.2% formamide,
agarose gel containing 18% formaldehyde and transferred onto Hy-





 standard saline citrate solution (1.5 M NaCl, 0.15 M sodium ci-
trate). The membrane was prehybridized in 10 ml of Hyb-9 solution
(Gentra Systems, Minneapolis, MN) for 1 hour. Full-length cDNA









Pharmacia Biotech) using the Megaprime DNA Labeling System
(Amersham Pharmacia Biotech) as per the manufacturer’s protocol.
After a 24-hour hybridization, the membrane was washed with low,
medium, and high stringency washes, and visualized by autoradiogra-




Cell lysates were separated by sodium dodecyl sulfate–polyacryla-
mide gel electrophoresis (10%), and then electroblotted to presoaked
Immobilon-P membranes (Millipore, Bedford, MA) for 18 hours at 40
mA constant current in transfer buffer (192 mM glycine, 20 mM Tris–
HCl, and 15% methanol). The membranes were blocked by soaking
in 1.5% bovine serum albumin in TBS-T (50 mM Tris–HCl, pH 7.5,
150 mM NaCl, and 0.05% Tween-20) solution for 2 hours at room
temperature. Each blot was incubated with rabbit polyclonal antibod-
ies to hOgg1 (Novus Biologicals, Littleton, CO) at a dilution of 1:500
at room temperature for 1–1.5 hours. The membranes were briefly
rinsed with deionized water and then washed five times with TBS-T
(50 mM Tris–HCl, pH 7.5, 150 mM NaCl, and 0.5% Tween 20) for 10
minutes per wash (35, 36). Secondary anti-rabbit peroxidase-conju-
gated antibodies (Sigma–Aldrich, St. Louis, MO) at 1:1,000 were then
added and incubated with the membrane at room temperature for 45
minutes. Finally, the membrane was extensively washed as previously
described and exposed on Kodak OMAT film using a chemilumines-




The hOgg1 activity of transduced cells was quantified by detecting
the cleavage of the 23-bp oligonucleotide substrate, containing a sin-





Figure 1. Construction and ex-
pression of retroviral vector con-
taining the hOgg1 or E. coli
Fpg coding regions. (a) Mam-
malian expression construct. From
5-end: LTR, spleen focus-form-
ing virus (SFFV), multiple clone
sites with the mIFN-	 insert
(EcoRI and SalI sites), internal ri-
bosome entry site, EGFP, and
3-end LTR. The transcript con-
tains EGFP, the vector’s splice
donor and splice acceptor sites,
and BER gene. (b) Expression
of EGFP in A549 cells. Phase
contrast (A, C) and fluorescence
(B, D) microscopy of retroviral-
transduced A549 cells express-
ing EGFP/hOgg1 (A, B—popu-










 (Trevigen, Gaithersburg, MD). Cell lysates from control




g protein samples) were





























-2-ethane sulfonic acid–KOH, pH 7.4, 10
mM KCl, 10 mM ethylenediamine tetraacetic acid [EDTA], and 0.1
mg/ml bovine serum albumin). The reaction was terminated by addi-
tion of 90% formamide loading buffer, and the samples were sepa-
rated by denaturing sodium dodecyl sulfate polyacrylamide gel (20%)
electrophoresis. The gel was dried and exposed on X-ray film. The rel-
ative fractions of full length and cut substrate were determined by
densitometric analysis using Kodak Analysis Software (Kodak, Roch-
ester, NY). Fpg activity was detected as described previously using a













A549 cells were grown in Dulbecco’s modified Eagle’s medium sup-


















 cells/ml. Next day, the cells
were subjected to hyperoxia in a NuAire Nu-3500 cell culture incuba-









 for 12, 24, 48, 72, and 96 hours. Control A549 cells








concentrations were monitored with a mini Oxygen Ted 60T meter









 9 mm Hg (38). At each time point, the
cells were harvested for assessment of DNA damage (Comet assay)





















 cells/dish overnight. Next day, the cells were washed with













M) at room temperature for 20
minutes. The cells were washed with PBS and used for assessment of




The Comet assay was performed according to the manufacturer’s in-
structions using a CometAssay kit (Trevigen). Briefly, after exposure of





























 cells/ml. The cell suspen-
sion was mixed with liquefied agarose at a 1:10 (vol/vol) ratio. A small
aliquot of this mixture was immediately transferred onto the slide pro-





C, slides were treated with alkali solution (0.3
M NaOH, 1 mM EDTA) for 60 minutes to unwind the double-stranded
DNA. Slides were electrophoresed at 1 volt/cm for 10 minutes. After
staining with SYBR green dye, samples were visualized and photo-
graphed by fluorescent microscopy using an Olympus BX60 Microscope
System and Paxit software (MIS, Franklin Park, IL). Tail length was de-
fined as the distance between the leading edge of the nucleus and the
end of the tail. Seventy-five determinations were made for each sample












 as described in previous
sections, 1 ml of trypsin–EDTA (0.25%:1 mM) was added to each





C. After the incubation, 5 ml of
media containing fetal bovine serum was added and the cells were re-
suspended. Viability of the cells was determined by trypan blue (0.4%
wt/vol) exclusion. The viable cells were then counted and plated at




 tissue culture plates.
After 10–14 days, the colonies were stained with 1% methylene blue









 test and analysis of variance were performed, and








Analysis of Transgene Expression
 





 Fpg gene into pSF91 (Figure 1a) from pGEX 4T-1
Fpg. Vector pSF91, derived from murine stem cell virus back-
bone and LN-based retroviral vectors, was used for transduc-
tion of A549 cells and hematopoietic progenitor cells (31, 33)
(Figure 1a). After selection for EGFP with fluorescence-acti-
vated cell sorting, more than 95% of the cells expressed EGFP
(Figure 1b). The A549 cell population expressing EGFP (Fig-
ure 1b) was serially diluted to isolate single clones. Clone 10 is
shown as representative of 27 clones selected (Figure 1b).
Northern blot analysis was performed to determine which
clones contained actively transcribed transgenes and the rela-
tive expression level for each colony (Figure 2). hOgg1 trans-
gene transcript is approximately 2 kb, which includes the vec-
tor’s splice donor and splice acceptor sites (Figure 2a). hOgg1
expression was also confirmed by Western blotting (Figure 2b).
Various amounts of hOgg1 expression were demonstrated, as
expected, at a molecular weight of 39 kD. Finally, the successful
expression of hOgg1 was displayed in an enzymatic cleavage ac-
tivity assay (Figure 2c). Similarly, the expression of Fpg in A549
cells was detected by Northern blot (Figure 2d). Enhanced Fpg
expression in A549 cells was also confirmed by enzyme cleav-




A population of hOgg1-expressing A549 cells showed less
DNA damage compared with vector-transduced control cells
(Figure 3A). As shown in a representative picture of the Comet
assay, exposure to hyperoxia for 3 days increased the tail length
in vector-transduced cells, but this was not seen in hOgg1-
transduced cells (Figure 3B). Similarly, a population of A549
cells expressing Fpg was protected from hyperoxia (Figure
Figure 2. Expression and activity analysis of hOgg1-transduced A549
cells. (A) Northern blot analysis of hOgg1 mRNA. Clones 2, 5, 10, 15,
and 16 expressing different amounts of hOgg1 mRNA. (B) Western
blotting analysis of hOgg1 protein. Clones 2, 5, 10, 15, and 16 express-
ing different amounts of hOgg1 protein. (C) hOgg1 enzyme activity
detected by oligonucleotide cleavage assay. Control, oligonucleotide
without cleavages; Clones 2, 5, 10, 15, and 16 expressing different
amounts of enzyme activity. Ten micrograms of cell-free extract reacted
with 2.5 pM 	-[32P]-dATP–labeled 8-oxoguanine–containing 23-bp oli-
gonucleotide for 60 minutes at 37
C. The cleavage product of reaction
was a 9-bp oligonucleotide. (D) Nouthern blot analysis of Fpg DNA ex-
pression.
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Figure 3. Effect of DNA BER
protein expression in A549 cell
population on O2-induced DNA
damage. A549 cells expressing
either hOgg1 or Fpg were in-
cubated in 95% O2 or room air
for 72 hours. DNA damage was
measured by Comet assay, and
tail length was defined as the
distance between the leading
edge of the nucleus and the
end of the tail. (A) A549 cell
population expressing hOgg1.
(B) Comet assay showing de-
creased DNA damage in hOgg1-
transduced A549 pop- ulation.
(C) A549 cell population ex-
pressing Fpg. *p  0.05, com-
pared with the vector control.
Figure 4. Effect of variable hOgg1 expression on DNA damage in hy-
peroxia. (A) Various A549 cell clones expressing different amounts of
hOgg1 activity were incubated in 95% O2 for 72 hours, and DNA dam-
age was detected by Comet assay (*p  0.05, compared with the vector
control). (B) Relationship between hOgg1 enzymatic activity and resis-
tance to hyperoxia. hOgg1 activity (oligonucleotide cleavage assay)
and DNA damage (tail length measured by the Comet assay) were
compared in A549 cell clones with variable expression of hOgg1 pro-
teins. The hOgg1 activity was expressed as a cleavage index (CI) indi-
cating the ratio of cleaved oligonucleotide to total oligonucleotide.
3C). We generated 27 A549/hOgg1 clones that variably ex-
pressed the transgene hOgg1. Eight clones (2, 5, 10, 12, 15–17,
and 26) were selected that expressed different levels of the
hOgg1 transgene; yet, each clone demonstrated significant pro-
tection from DNA damage when incubated in hyperoxia (Fig-
ure 4A).
We assessed the relationship between hOgg1 activity and
resistance to DNA damage during hyperoxia. The results showed
that the levels of hOgg1 DNA repair activity in various A549
cell clones correlated with resistance to hyperoxic DNA dam-
age in A549 cells (r  0.79, p  0.05) (Figure 4B). Although a
correlation exists, hOgg1 activity in an individual A549 cell
clone does not reliably predict the degree of protection from
hyperoxia.
A549 cells expressing either hOgg1 or Fpg demonstrated
longer survival compared with the vector-transduced control cells
(p  0.05, Figures 5A and 5B). However, there were no significant
differences between Fpg and hOgg1 in the ability to protect the
cells from hyperoxia. Similarly, five hOgg1 clones (2, 5, 10, 15,
and 16) expressing significantly different levels of the hOgg1
transgene demonstrated a similar ability to sustain cell survival
during hyperoxia (Figure 6A). The relationship between hOgg1
activity and cell survival demonstrated only a marginal correla-
tion (r  0.55, p  0.05) (Figure 6B). Further, the correlation
between DNA damage and cell survival in the hOgg1 clones
was also marginal (r  0.54, p  0.05).
Protection from H2O2
To assess whether overexpression of BER genes would afford
protection from H2O2, DNA damage and cell survival were as-
sayed in lung cells overexpressing hOgg1 or Fpg in the pres-
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ence or absence of H2O2. Overexpression of hOgg1 or Fpg sig-
nificantly protected against DNA damage by H2O2 (0–1,000
M) compared with the vector-transduced control cells (p 
0.05, Figures 7A and 7B). Further, overexpression of hOgg1
partially enhanced cell survival in the presence of H2O2 (200
and 1,000 M) compared with the vector-transduced control
cells (p  0.05), whereas overexpression of Fpg did not en-
hance cell survival (Figures 7C and 7D). These data suggest
that H2O2 might injure DNA of lung cells in a manner different
from hyperoxia, and that the protective effects of BER pro-
teins such as hOgg1 or Fpg on cell survival also differ.
DISCUSSION
We report a successful reduction in oxygen toxicity to lung
cells by overexpression of BER repair proteins in these cells.
Using an improved bicistronic retroviral vector (33, 39), we
were able to transduce lung epithelial cells with either hOgg1
or Fpg DNA to achieve protein overexpression with each trans-
gene. Overexpression of hOgg1 or Fpg protected the lung cells
from hyperoxia-induced injury as demonstrated by either DNA
damage or cell survival assays. This is the first study to show
that overexpression of DNA BER proteins can be protective
from oxygen toxicity in lung cells.
High concentrations of oxygen likely damage DNA of lung
cells by forming an array of reduced ROS (9, 13). Evidence
that DNA is a target for this damage is provided by the in-
crease in DNA damage–inducible proteins such as p53 and
p21 in the lung during hyperoxia (10, 13, 40). In a manner sim-
ilar to hyperoxia, bleomycin induces p53 and p21 expression,
and this has been localized to type II alveolar epithelial cells in
the lung (11). Of interest, hyperoxia is a frequently suspected
cofactor in clinical bleomycin toxicity (41). Bleomycin gener-
ates DNA lesions typical of the injury/repair cycle associated
with oxidant damage (42). Widespread injury to the alveolar
epithelium by hyperoxia or drugs may jeopardize the integrity
of the lung. Type II cell injury and death is a catastrophic
event for the alveolar unit as the type II cell is the progenitor
of the type I alveolar epithelial cell (43) and is the major
source of pulmonary surfactant proteins (44). New strategies
are needed to protect alveolar epithelial cells from O2 toxicity.
Our study suggests one approach to achieving protection is to
rapidly reverse O2-induced DNA damage (Figure 8).
Recognition and removal of 8-oxoguanine residues from
DNA is dependent on similar enzymes in bacterial and eukary-
otic cells. The Fpg and hOgg1 DNA glycosylases recognize and
initiate repair of 8-oxoguanine and formamidopyrimidine le-
sions produced by oxidative and alkylative DNA damage, re-
spectively. The BER genes release the modified base from the
sugar molecule of a nucleotide leaving an apurinic/apyrimi-
dinic (AP) site in the DNA (45). After release of the damaged
bases, downstream enzymes, including AP endonucleases (Ape1),
DNA polymerase-, and DNA ligase, continue the repairing pro-
cess by filling and sealing the gap (26, 45).
Both hOgg1 and Fpg have AP lyase activity for removing
5-terminal deoxyribose phosphate flanking the DNA strand
breaks next to abasic sites (46), although Fpg is more active in
this respect than hOgg1 (47). Recent studies have shown that
hOgg1 is a strong glycosylase but a much weaker AP lyase
(47). It has been suggested that hOgg1 acts with other mem-
bers of the BER pathway, namely the major AP endonuclease
(Ape1/ref-1) or -polymerase, to augment its inherent low
lyase activity during hydrolytic processing of the AP site (47).
This has been confirmed for the human T–G mismatch glyco-
sylase that is dislocated by Ape1/ref-1 (48). However, en-
zymes downstream to hOgg1 may be rate-limiting in human
Figure 5. Effect of DNA BER protein expression on cell survival. A549
cells expressing hOgg1 or Fpg were incubated in 95% O2, and cell sur-
vival was measured by colony forming assay. Cell survival was expressed
as percentage of surviving colonies in hyperoxia to surviving colonies in
room air. (A) A549 cell population expressing hOgg1. (B) A549 cell pop-
ulation expressing Fpg. *p  0.05, compared with the vector control.
Figure 6. Effect of variable hOgg1 expression on cell survival in hyper-
oxia. (A) A549 cell clones expressing different amounts of hOgg1 were
incubated in hyperoxia, and cell survival was measured by colony form-
ing assay (*p  0.05, compared with the vector control). (B) Relation-
ship between hOgg1 enzymatic activity and resistance to hyperoxia-
induced toxicity (r  0.55, p  0.05).
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cells (31, 49). It would be interesting to determine if increased
expression of these downstream enzymes (Ape1/ref-1 and/or
-polymerase) will augment cell survival with coexpression of
either hOgg1 or Fpg (31).
Our studies also demonstrate that cells overexpressing
hOgg1 or Fpg were protected from the cytotoxic effects of ex-
posure to H2O2. Among various lesions associated with oxida-
tive DNA damage, 8-oxoG is the most important because of
its abundance and mutagenicity. 8-oxoG and formamidopyri-
midine are both substrates for Fpg and hOgg1 (50); however,
recent studies have shown that the rate of excision of 7-me-
thyl-formamidopyrimidine by hOgg1 is less than that of Fpg
(51). hOgg1 and Fpg exhibit both N-glycosylase and 3 and 5
-lyase activities for the removal of deoxyribose phosphate.
Therefore, protection against H2O2 as evidenced in our study
might be mediated by these other activities.
Although exposure to H2O2 is often used as a surrogate for
ROS damage generated during hyperoxia, it is unclear if H2O2
causes a similar type of DNA damage. Studies in Chinese
hamster ovary cells revealed that H2O2 produces mutagenic
single-strand DNA damage, whereas hyperoxia causes sister
chromatid exchanges and other chromosome aberrations (52).
Iron chelators enhance survival of cells exposed to H2O2, but
not when exposed to hyperoxia (53). The toxicity of H2O2 is
probably dependent on the formation of hydroxyl radicals
(•OH) through the Fenton reaction, as scavengers of ROS re-
duce •OH formation and prevent the lethal action of H2O2
(13, 54). However, hydrogen peroxide has direct effects on re-
dox-signaling pathways, independent of hydroxyl radical for-
mation (55).
Although overexpression of BER proteins in lung cells
protected from hyperoxia-induced DNA damage, it appears
that BER proteins were less effective in protecting the cells
from cell death. These findings are consistent with a role for
DNA damage to be a contributing but not sole mechanism of
hyperoxia-induced cell death. Apoptosis is generally consid-
ered to be the predominant mode of cell death from oxidative
insults (56), which is controlled by complex signaling involving
many regulatory proteins such as DNA damage–inducible
proteins, proinflammatory factors, and cell cycle regulation ki-
nases (57). However, necrosis during acute lung injury is also
observed, particularly in A549 cells under hyperoxic condition
(58), suggesting a dual mode of cell death (59). Other factors
such as cell types and confluence state may determine the
mode of cell death (60). Thus, we speculate that enhanced ex-
pression of BER proteins in A549 cells may protect from one
type of hyperoxia-induced cell injury but not another. A limi-
tation to the use of A549 cells is that they might also not accu-
rately reflect the degree of DNA damage or repair that occurs
to alveolar epithelial cells in vivo.
In summary, we have been able to successfully reduce hy-
peroxia-induced DNA damage to lung cells by overexpression
of DNA BER protein hOgg1 or Fpg. This is the first study to
demonstrate that DNA BER proteins have protective effects
on reducing O2 toxicity in lung cells. Our data suggest that in-
creased expression of DNA BER genes might represent a new
approach for protecting critical lung cells from the toxic ef-
fects of hyperoxia.
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